Prospective correlation between tissue-resident immune cell subsets and graft-versus-host disease after hematopoietic stem cell transplantation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500100300

Enrollment

Unknown

Registered

2025-04-07

Start date

2024-02-10

Completion date

Unknown

Last updated

2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute graft-versus-host disease

Interventions

control group:N/A

disease group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Voluntarily sign informed consent; 2. Age>= 18 years old; 3.No gender limitation; 4.Patients develop graft-versus-host disease at the discretion of the treating physician;

Exclusion criteria

Exclusion criteria: 1.History of other tumors; 2.Patients with poor compliance or mental disorders; 3.HIVHCV infected;patients with uncontrolled EBV infection; 4.Patients with other autoimmune disease; 5.The researchers judged that it is not suitable to participate in this study;

Design outcomes

Primary

Measure	Time frame
Occurrence of intestinal acute graft-vesus-host disease;	—

Secondary

Measure	Time frame
relapse;Occurrence of intestinal chronic graft-vesus-host disease;Prognosis and outcome of patients treated with graft-vesus-host disease;	—

Countries

China

Contacts

Public ContactJin Hua

Southern Medical University Southern Hospital

jinhua871124@163.com+86 18026280868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026